Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LotusFlare Teams Up with T-Mobile for Strategic Technology Innovation 2023-11-28 08:00
Bright Scholar Announces Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year 2023 2023-11-28 07:00
Cango Inc. Reports Third Quarter 2023 Unaudited Financial Results 2023-11-28 05:30
Fidelis New Energy's Norne Carbon Storage Hub Declared a Project of Common Interest by the European Union 2023-11-28 05:21
SAS awarded IFRS 17 solution of the year by Asia Risk Awards 2023-11-28 03:08
Abu Dhabi Finance Week Charts the Rise of the Falcon Economy with the Launch of Abu Dhabi Economic Forum 2023-11-28 03:01
Wollemi launches to solve multi-trillion dollar emissions problem 2023-11-28 03:00
AV-Comparatives Unveils Results of Its 2023 Advanced Threat Protection Tests for market leading Enterprise and Consumer Cybersecurity Products 2023-11-28 00:56
/C O R R E C T I O N -- SmartKem, Inc./ 2023-11-28 00:44
Ministry of Human Resources and Social Development Reaffirms Commitment to Worker Productivity Growth and Collaborative Policies 2023-11-28 00:02
STRADVISION Drives Global Business Expansion with Public Cloud ERP 2023-11-28 00:00
"World Youth Energy Tour" Kicks off in Beijing 2023-11-27 23:00
International Bladder Cancer Group (IBCG) and UroToday Announce Formal Partnership to Enhance Patient Outreach 2023-11-27 22:30
Farmmi Ships High-Volume Repeat Order to Chile; Company Sees Golden Age for Mushrooms 2023-11-27 22:16
AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology 2023-11-27 22:05
Brown 's stories with China 2023-11-27 22:00
Inter(World)View, Interview the World 2023-11-27 22:00
NWTN and Partners to Exhibit Technologies for Full Clean Energy Value Chain at COP28 in Dubai, UAE 2023-11-27 22:00
AnotherBall, the Company Behind IZUMO, Secures $12.7M in Seed Funding, Surpassing $14.8M in Total Funding 2023-11-27 22:00
Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients 2023-11-27 21:30
1 846 847 848 849 850 11827